ARTICLE | Clinical News
AG7088: Began Phase II trial
November 8, 1999 8:00 AM UTC
Agouron Pharmaceuticals Inc., La Jolla, Calif. Product: AG7088 Business: Infectious diseases Therapeutic category: Viral replication Target: Rhinovirus 3C protease Description: Intranasal inhibitor o...